Increasing prevalence of infectious diseases and life-threatening diseases such as Nipah and COVID-19 strains, high risk of emergence of novel diseases, and rising investments and funding by public and private organizations are expected to drive global market growth.
Increasing prevalence of infectious diseases and life-threatening diseases such as Nipah and COVID-19 strains, high risk of emergence of novel diseases, and rising investments and funding by public and private organizations are expected to drive global market growth
According to Emergen Research, the global biodefense market size was USD 13.08 billion in 2020 and is expected to reach USD 20.13 billion in 2028 and register a steady revenue CAGR of 5.8% during the forecast period, 2021-2028.
Market Dynamics:
Bioterrorism is the deliberate release of bacteria, viruses, fungi, and other infectious agents to cause death or illness among large number of people or communities. Biodefense refers to measures taken to protect individuals against bioterrorism. This includes medicines, vaccinations, research along with health preparation for populations to defend themselves from biological attacks. Factors such as increasing efforts taken by governments to stock vaccines and protect against economic damages caused by biological attacks and rising investments in developing vaccines and advanced biothreat detection technologies are expected to fuel market revenue growth during the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/905
In addition, increasing research-based activities, rising investments in vaccine development, and high focus on improving medical preparedness against biological warfare are expected to fuel global market growth going ahead. However, factors such as low awareness about biodefense in many developing and underdeveloped countries, insufficient funds for research and development activities, lack of healthcare infrastructure for manufacturing vaccines in underdeveloped economies are expected to hamper market growth to a certain extent during the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Anthrax Vaccine Segment to Account for largest Revenue Share:
The anthrax vaccine segment is expected to account for largest revenue share during the forecast period owing to high prevalence of anthrax in many parts of the world, rising investments and funds for anthrax vaccine development, and increasing efforts by various organizations to create awareness about anthrax disease and importance of vaccination worldwide.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/biodefense-market
Military Segment To Register Rapid Revenue CAGR:
The military segment is expected to register rapid revenue CAGR during the forecast period. Revenue growth can be attributed to factors such as increasing threat of bioterrorism, high risk of acquiring infections to military personnel through natural or unnatural forms, rapid advancements in vaccine development, and rising investments in developing vaccines to cater to emergence of viruses such as Ebola, Zika, and COVID-19.
North America to Lead In Terms of Revenue Share:
North America is expected to account for largest revenue share in the global market between 2021 and 2028 owing to increasing awareness about biological threats, presence of leading organizations and government initiatives to protect civilians against potential biological threats, and rising threat of bioterrorism. Other factors such as rapid technological advancements, high demand for biodefense due to outbreak of COVID-19, increasing number of pharmaceutical and biotechnology companies and research organizations, and rising investments in research and development activities are expected to drive North America market growth during the forecast period.
Major Companies in the Market Include:
- CanSino Biologics
- BioNTech SE
- Altimmune
- Emergent BioSolutions Inc.
- SIGA Technologies, Inc.
- Cleveland BioLabs, Inc.
- Alnylam Pharmaceuticals Inc.
- Elusys Therapeutics
- DynPort Vaccine Company LLC
- Ichor Medical Systems Inc.
- AstraZeneca Plc
- Serum Institute of India
- Wuhan Institute of Biological Products
- Inovio Pharmaceuticals Inc.
- SinovacBiotech Ltd.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/905
For the purpose of this report, Emergen Research has segmented the global biodefense market on the basis of product type, biothreat detection device type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- COVID-19 Vaccine
- Anthrax Vaccine
- Smallpox Vaccine
- Botulism Vaccine
- Others
Biothreat Detection Device Type Outlook (Revenue, USD Billion; 2018-2028)
- Sampler
- Triggering Devices
- Identifier
- Others
End-use Outlook (Revenue, USD Billion; 2018–2028)
- Hospital and Clinics
- Ambulatory Care Centre
- Research Organizations
- Military
- Others
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/905
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@ https://www.emergenresearch.com/call-schedule/905
Read Latest Reports Published by Emergen Research:
Food Enzymes Market By Source (Microorganisms, Animals, Plants), By Product Type (Carbohydrase, Protease, Lipase Polymerases, Nucleases), By Application (Food, Beverages), and By Region Forecast to 2028.
Food Thickeners Market By Type (Starch, Protein, Hydrocolloids), By Source (Microbial, Animal, Plant), By Application (Confectionery, Bakery, Beverages, Sauces, Dressings, Marinades, and Gravies, Convenience & Processed Food, Dairy & Frozen Desserts, Others), and By Region Forecast to 2028.
Food Traceability Market By Equipment (Sensors, PDA with GPS and Others), By Software (Warehouse Software, Enterprise Resource Planning and Others), By Technology (GPS, Barcode, and Others), By Application, By End-Use, and By Region Forecast to 2028.
Non Thermal Pasteurization Market By Food Form (Liquid, Solid), By Technique (PEF, HPP, MVH, Ultrasonic, Irradiation), By Application (Food, Beverages, Pharmaceutical and Cosmetics), and By Region Forecast to 2028.
Nutraceutical Ingredients Market By Form (Liquid, Dry), By Type (Proteins and amino acids, Probiotic, Prebiotic, Vitamins, Minerals), By Application, and By Region Forecast to 2028.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-biodefense-market